Citius Pharmaceuticals, Inc.
CTXRQ4 FY2026Period ended Sep 30, 2026
- Fiscal period
- Q4 FY2026
- Period end
- 2026-09-30
- Report due by
- 2026-12-25from the company's last four reports
- Margin metric
- Gross margin
- Status
- Locked
- Scored against
- The 10-K, with Q4 derived as the year less three quarters
- Locks
- Locked Oct 26, 2026, 16:05 ET
Locked
Forecasts locked Oct 26, 2026, 16:05 ET, when EDGAR accepted Citius Pharmaceuticals, Inc.'s 8-K (2.02 Results of operations), accession 0001213900-26-112478. Anything saved after that second does not count.
Forecasts
Members with a public profile.
No public forecasts on this target.